Psychological aspects of PSA testing

Nature Reviews Urology

Volumn 6, Issue 9, 2009, Pages 513-515

  Torta, Riccardo G V ^a   Munari, Jacopo ^a  

^a Department of Clinical and Oncologic Psychology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANXIETY; ARTICLE; COPING BEHAVIOR; DOCTOR PATIENT RELATION; EMOTIONAL STRESS; HUMAN; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; SCREENING TEST;

DIAGNOSTIC TESTS, ROUTINE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSYCHOLOGY;

EID: 70349099552     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2009.146     Document Type: Article

References (25)

1. Essink-Bot, M. L. et al. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J. Natl Cancer Inst. 90, 925-931 (1998).
2. Oliffe, J. Being screened for prostate cancer: A simple blood test or a commitment to treatment? Cancer Nurs. 29, 1-8 (2006).
3. Schulmann, C. C., Kirby, R. & Fitzpatrick, J. M. Awareness of prostate cancer among the general public: Findings of an independent international survey. Eur. Urol. 44, 294-302 (2003).
4. Hewitson, P. & Austoker, J. Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. BJU Int. 95 (Suppl. 3), 16-32 (2005).
5. Chan, E. C. et al., Informed consent for cancer screening with prostate-specific antigen: How well are men getting the message? Am. J. Public Health 93, 779-785 (2003).
6. Wolf, A. M., Nasser, J. F., Wolf, A. M. & Schorling, J. B. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch. Intern. Med. 156, 1333-1336 (1996).
7. Dale, W., Bilir, P., Han, M. & Meltzer, D. The role of anxiety in prostate carcinoma: A structured review of the literature. Cancer 104, 467-478 (2005).
8. Gattellari, M. & Ward, J. E. Men's reactions to disclosed and undisclosed opportunistic PSA screening for prostate cancer. Med. J. Aust. 182, 386-389 (2005).
9. Gattellari, M. & Ward, J. E. A community study using specified and unspecified scenarios to investigate men's views about PSA screening. Health Expect. 7, 274-289 (2004).
10. Carlsson, S., Aus, G., Wessman, C. & Hugosson, J. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - results from a prospective, population-based, randomised study. Eur. J. Cancer 43, 2109-2116 (2007).
11. Brindle, L. A. et al. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int. 93, 777-782 (2006).
12. Macefield, R. C. et al. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy? Eur. J. Cancer doi:10.1016/ j.ejca.2009.03.016.
13. Roth, A. et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 97, 2910-2918 (2003).
14. Roth, A. & Passik, S. Anxiety in men with prostate cancer may interfere with effective management of the disease. Primary Care Cancer 16, 30-37 (1996).
15. Lofters, A., Juffs, H. G., Pond, G. R. & Tannock, I. F. "PSA-itis": knowledge of serum prostate specific antigen and other causes of anxiety in men with metastatic prostate cancer. J. Urol. 168, 2516-2520 (2002).
16. Christie, K. M., Meyerowitz, B. E., Giedzinskasimons, A., Gross, M. & Agus, D. B. Predictors of affect following treatment decision-making for prostate cancer: Conversations, cognitive processing, and coping. Psychooncology 18, 508-514 (2009).
17. Wilkinson, S., Warren, K., Ramsden, A., Matthews, A. & Chodak, G. Do "rapid" PSA assays reduce anxiety and stress of prostate cancer patients undergoing regular review? A prospective evaluation. Urology 71, 567-572 (2008).
18. Varetto, A. & Torta, R. La comunicazione e il consenso informato. In Psiconcologia. Il modello biopsicosociale (Eds Torta, R. & Mussa, A.) 89-110 (Centro Scientifico Editore, Torino, 2007).
19. Costantini, A. et al. Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: Psychological aspects of physician-patient communication. Ann. Oncol. doi:10.1093/annonc/ mdp057 (in press).
20. Ward, J. E., Gupta, L. & Taylor, N. Do general practitioners use prostate-specific antigen as a screening test for early prostate cancer? Med. J. Aust. 169, 29-31 (1998).
21. Whitson, J. M. & Konety, B. R. Should men over the age of 65 years receive PSA screening? Argument in favor. Nat. Clin. Pract. Urol. 5, 230-231 (2008).
22. Albertsen, P. C. Should men over the age of 65 years receive PSA screening? Argument against. Nat. Clin. Pract. Urol. 5, 232-233 (2008).
23. Gattellari, M. et al. Does 'peer coaching' increase Gp capacity to promote informed decision making about psA screening? A cluster randomised trial. Fam. Pract. 22, 253-265 (2005).
24. Baile, W. F. et al. SPIKES - a six-step protocol for delivering bad news: Application to the patient with cancer. Oncologist 5 302-311 (2000).
25. Back, A. L., Arnold, R. M., Tulsky, J. A., Baile, W. F. & Fryer-Edwards, K. A. Teaching communication skills to medical oncology fellows. J. Clin. Oncol. 21, 2433-2436 (2003).